Was it the example of cold-shouldered
wedding-ring king Tiffany & Co.
(NYSE:TIF), which tumbled 4.42%? (The company is currently sponsoring the US Open
but in tennis, as apparently in life, love means nothing.) The separation of Michael Douglas and Catherine Zeta-Jones
, who even shared the same birthday, so perfect did they seem for each other? Or perhaps the split between Google’s (NASDAQ:GOOG) co-founder and his wife
? Whatever the inspiration, Dow Industrials
(INDEXDJX:.DJI) decided to decouple from the crisis in Damascus for a day and end up for the first time all week. Fifty years to the day after a black man memorably said “I have a dream,” a 2.59% surge in Xerox
(NYSE:XRX), headed by an African-American woman who once interned at the tech giant, showed how far we have come, even as it emerged that Wall Street still has so much to do
in the area of race relations. Elsewhere diamond seller Zale Corp
(NYSE:ZLC) jumped 29.80%, having clearly come a long way from its 1920s roots when the company’s novel credit policy promised customers “a penny down and a dollar a week.” That Penney
(NYSE:JCP) down part is still about right, with the increasingly troubled retailer slumping another 3.11%.
In today’s corporate earnings action, Campbell Soup
(NYSE:CPB), JA Solar
(NASDAQ: JASO), Krispy Kreme Doughnuts
(OTCMKTS:LRLCY), Pall Corp
(NYSE:PLL), Pernod Ricard
(NYSE:CRM), Signet Jewelers
(OTCMKTS:VIVHY), and WPP Plc
(OTCMKTS:WPPGF) are all due to release results.
ImmunoCellular Therapeutics Ltd
(NYSEMKT:IMUC): The biotech is begun with a Buy at Lazard, whose price objective is $5.
(NYSE:NOW): Robert W. Baird has a new Neutral, and $52 target price, on a company whose two impressive cloud products are currently balanced out by a relatively hefty valuation of 11 times estimated 2014 revenue.
Sovran Self Storage Inc
(NYSE:SSS): The industrial Real Estate Investment Trust is assigned an Outperform at Raymond James.
Stemline Therapeutics Inc
(NASDAQ:STML): Jefferies resumes Buy-rated research on the biotech.
(NYSE:TDC): Longbow launches the tech name at a Neutral.
Xenith Bankshares Inc
(NASDAQ:XBKS): The financial firm is covered with a Market Perform at Keefe Bruyette, whose objective is $6.50.
(See also: Stock Upgrades: AMC Networks Is No Dead Man Walking
and Stock Downgrades: Rotten Tomatoes for The Fresh Market
No positions in stocks mentioned.
The information on this website solely reflects the analysis of or opinion about the performance of securities and financial markets by the writers whose articles appear on the site. The views expressed by the writers are not necessarily the views of Minyanville Media, Inc. or members of its management. Nothing contained on the website is intended to constitute a recommendation or advice addressed to an individual investor or category of investors to purchase, sell or hold any security, or to take any action with respect to the prospective movement of the securities markets or to solicit the purchase or sale of any security. Any investment decisions must be made by the reader either individually or in consultation with his or her investment professional. Minyanville writers and staff may trade or hold positions in securities that are discussed in articles appearing on the website. Writers of articles are required to disclose whether they have a position in any stock or fund discussed in an article, but are not permitted to disclose the size or direction of the position. Nothing on this website is intended to solicit business of any kind for a writer's business or fund. Minyanville management and staff as well as contributing writers will not respond to emails or other communications requesting investment advice.
Copyright 2011 Minyanville Media, Inc. All Rights Reserved.